Target intelligence / Profile preview

Vomeronasal 1 receptor 99 pseudogene (VN1R99P)

Target
VN1R99P
Molecular classification
Pseudogene, Putative G protein-coupled receptor (by ancestral family classification)
01

Overview

The vomeronasal 1 receptor 99 pseudogene (VN1R99P) is a non-coding member of the vomeronasal receptor family; it is not functional in humans, encodes no protein, and is not involved in any known cellular or disease processes.

Other names
VN1R99Pvomeronasal 1 receptor 99 pseudogeneENSG00000277562100312842 (NCBI Gene)
02

Biological functions

Other (ancestral function in pheromone detection in other species; no function in humans)

Beyond the preview

Go deeper on Vomeronasal 1 receptor 99 pseudogene (VN1R99P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vomeronasal 1 receptor 99 pseudogene (VN1R99P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call